Sector | Healthcare |
Industry | - |
Day Range | 0.90 | 1.05 |
52-Wk Range | - | - |
Last Close | 0.97 |
Mkt Cap (m) | 165.97 |
Dividend yield | - |
ISIN | US04546C1062 |
Volume | 13,776,754.00 |
Exchange Venue | NAS |
Depomed Inc is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system.
Price/Earning | - |
Price/Book | 2.19 |
Price/Sales | 0.68 |
P/CF | - |
Rev Growth (3 year avg) | - |
EPS Growth (3 year avg) | - |
Operating Margin % | - |
Net Margin % | - |
Return on Equity | - |
Debt/Equity | - |
en 11/02/2021 |
en 31/12/2019 |
Please refer to the below issuer website for further documents.
USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Revenue (m) | 342.74 | 455.90 | 380.72 | 311.77 | 229.50 | - |
Operating Income (m) | -80.30 | 24.51 | -28.93 | 64.26 | -0.75 | - |
Net Income (m) | -75.74 | -88.72 | -102.50 | 36.91 | -217.20 | - |
Basic EPS | -1.26 | -1.45 | -1.63 | 0.58 | -3.07 | - |
Avg. Diluted Shares Outstanding (m) | 60.12 | 61.30 | 62.70 | 64.21 | 70.72 | - |
USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Current Assets (m) | 308.97 | 306.20 | 230.85 | 208.11 | 103.95 | - |
Non Current Assets (m) | 1,054.46 | 919.13 | 807.77 | 724.76 | 423.22 | - |
Total Assets (m) | 1,363.43 | 1,225.34 | 1,038.62 | 932.87 | 527.17 | - |
Current Liabilities (m) | 219.63 | 227.24 | 310.58 | 246.04 | 184.55 | - |
Total Liabilities (m) | - | - | - | - | - | - |
Total Equity (m) | 315.06 | 250.79 | 169.51 | 220.34 | 57.96 | - |
USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Operating Cash Flows (m) | 143.89 | 65.50 | 62.17 | 72.50 | 90.48 | - |
Capital Expenditure (m) | -26.72 | -2.86 | -0.67 | -5.51 | -1.48 | - |